Advertisment
|
|
|
news roundup
|
advertisment
Immuno-Oncology Insights:
Top 5 Challenges in Today's Immuno-Oncology Trials
Live webinar: Thurs., April 7, 2016 at 11 am – 12 pm EDT
Learn about the top 5 challenges of immuno-oncology clinical trials, and get practical insights for your clinical development program.
 Register now
|
goBalto offers a platform for cloud-based study startup clinical trials, from site feasibility assessment and selection through to activation, with metrics to track adherence to timelines and budget.
|
advertisment
Overcoming regulatory and statistical hurdles of biosimilars drug development
Designing smarter trials
Live webinar: Wed., April 6, 2016 at 11 am
 Register here
|
|
|
|
|
advertisment
Acquiring, Tracking and Maintaining Biological Study Samples for Complex Study Designs
On Demand
 Read more
|
Subscribe
|
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »
|
|
|
|
Advertisment
|
|
|
articles
Many organizations have a constant need to expand CTMS capabilities, integrate clinical operations data across multiple systems, and update clinical trial processes.
|
advertisment
Mitigating risk using Risk-based Monitoring
On Demand
Learn how risk-based monitoring (RBM) is transforming clinical development by mitigating risk while optimizing execution. Understand how to achieve enhanced patient safety with improved quality to execute your RBM studies with confidence.
 Read more
|
|
|
|
Blog Posts
The outcome of any inspection or audit is a blend of the compliance level of the inspected site, Inspector/Auditor and reviewing agency competence, and how well the audit or inspection is managed.
|
advertisment
Advancing Drug Development with Digital Health
4 Key Ways to integrate Patient - Generated Data into Trials
On Demand
 Read more
|
|
|
|
RBM
Considering the scope of centralized monitoring and RBM processes, the central monitor role has key responsibilities and attributes.
Wingspan eTMF’s newest release features a placeholder feature for visit documents, as they are scheduled.
When applying a risk-based approach to clinical trials, one needs to identify the risks to the critical data and processes that are very important to achieve the study objectives.
|
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription
|
|
|
|
|
